Acarix AB (SE:ACARIX)
:ACARIX
Want to see SE:ACARIX full AI Analyst Report?
ACARIX Stock Chart & Stats
kr0.28
>-kr0.01(-3.04%)
At close: 4:00 PM EST
kr0.28
>-kr0.01(-3.04%)
Day’s Range― - ―
52-Week Rangekr0.19 - kr0.47
Previous CloseN/A
Volume265.37K
Average Volume (3M)1.57M
Market Cap
kr312.28M
Enterprise Valuekr294.01M
Total Cash (Recent Filing)kr18.27M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.22
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,123,320,200
10 Day Avg. Volume1,780,482
30 Day Avg. Volume1,572,056
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)7.91
Price to Sales (P/S)41.02
P/FCF Ratio-6.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)kr19.80M
Bulls Say, Bears Say
Bulls Say
Business Model (hardware + Recurring Consumables)A dual revenue model of device sales plus recurring consumables and service creates a structural revenue stream tied to usage. Over 2–6 months this supports predictable per-test economics, incentivizes customer retention and provides a path to higher lifetime value as install base grows.
Positive Product-level EconomicsSustained positive gross margins mean the CADScor technology can be monetized profitably at the unit level. This durability implies that, with scale, incremental revenue can flow to operating leverage, improving sustainability even if SG&A is currently high.
Low LeverageMinimal debt reduces default and interest risks and preserves strategic optionality. Over the medium term this lowers fixed financial burden, eases covenant pressure, and gives management flexibility to prioritize commercialization or R&D without immediate debt repayment constraints.
Bears Say
High Cash BurnPersistent large negative operating and free cash flow indicate the business cannot self-fund near-term expansion. Continued burn will require external financing, increasing dilution or refinancing risk, and constrains long-term investments unless revenue scaling materially accelerates.
Balance-sheet ErosionMaterial decline in shareholders' equity reflects accumulated losses and shrinking capital base, reducing the firm’s buffer against shocks. Over months this weakens creditworthiness and increases dependence on capital markets for runway, raising execution risk for commercialization.
Cost Structure Ahead Of ScaleOperating costs far exceed current revenue, implying fixed-cost intensity and a long path to breakeven unless top-line growth accelerates sharply. Structural mismatch between expenses and sales heightens sensitivity to slower adoption and requires clear scaling or cost-reduction plans.
Acarix AB News
ACARIX FAQ
What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was kr0.19 and its highest was kr0.47 in the past 12 months.
What is Acarix AB’s market cap?
Acarix AB’s market cap is kr312.28M.
When is Acarix AB’s upcoming earnings report date?
Acarix AB’s upcoming earnings report date is May 20, 2026 which is in 19 days.
How were Acarix AB’s earnings last quarter?
Acarix AB released its earnings results on Feb 12, 2026. The company reported -kr0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.01.
Is Acarix AB overvalued?
According to Wall Street analysts Acarix AB’s price is currently Overvalued.
Does Acarix AB pay dividends?
Acarix AB does not currently pay dividends.
What is Acarix AB’s EPS estimate?
Acarix AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acarix AB have?
Acarix AB has 1,123,320,200 shares outstanding.
What happened to Acarix AB’s price movement after its last earnings report?
Acarix AB reported an EPS of -kr0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.649%.
Which hedge fund is a major shareholder of Acarix AB?
Currently, no hedge funds are holding shares in SE:ACARIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acarix AB
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.